Business Segments GENFIT Deutsche Boerse AG

Stocks

XUP

FR0004163111

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG 10:06:15 17/09/2026 +04			5-day change	1st Jan Change
11.94 ^EUR	+2.05%		0.00%	+127.65%

09-15	French and Benelux stocks-Factors to watch on September 15	RE
09-15	France's Genfit Plans Phase 2a Trial of Liver Failure Treatment	MT

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Geographical Revenue Distribution History

Breakdown by Business Segment (EUR)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Research and Development of Innovative Medicines and Diagnostic Solutions						85.36M	26.25M	34.48M	70.69M	70.84M
Total Assets						282M	216M	174M	151M	159M
Interest Expense						-4.96M	-4.41M	-4.62M	-4.75M	-5.23M
Income Tax Expense						2.22M	-116K	380K	340K	-531K
CAPEX						-537K	-	-414K	-979K	-1.39M
EBT						69.47M	-23.84M	-28.51M	1.85M	-86.5M
D&A						2.59M	1.75M	1.59M	1.71M	1.83M
Operating Income						31.82M	-27.29M	-26.58M	3.28M	-53.63M
Net Income						67.26M	-23.72M	-28.89M	1.51M	-85.97M

Geographical breakdown of sales (EUR)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
France						-	20.2M	28.56M	67M	65.43M
Total Assets						-	12.92M	13.87M	12.58M	12.58M
Total Assets						-	44.16M	46.89M	46.08M	46.08M

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!